Next, we expanded our analysis of TIMP1 to a larger cohort of mice (N = 127) and confirmed that it continued to be specifically elevated in tumour‐bearing mice (Figure 1C) and performed well as a biomarker (Figure 1D). This evidence concerns the gene TIMP1 and neoplasm.